The Promise of Low-Dose Aspirin on Longevity in the Geriatric Population: No Effect on Outcomes in the US and Australia Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 10/17/2018 https://www.nejm.org/doi/full/10.1056/NEJMoa1800722 Effect of Aspirin on Disability-free Survival in the Elderly ORIGINAL ARTICLE Effect of Aspirin on Disability-free Survival in the Healthy Elderly J.J. McNeil and Others […]
Search Results for 'Aspirin'
The Promise of Low-Dose Aspirin on Longevity in the Geriatric Population: No Effect on Outcomes in the US and Australia
Posted in Atherogenic Processes & Pathology, Cardiovascular Research, Coagulation Therapy and Internal Bleeding, Frontiers in Cardiology and Cardiovascular Disorders, HTN, inflammation independent of lipid levels, Pharmacotherapy of Cardiovascular Disease, Stroke on September 24, 2018| Leave a Comment »
Most Popular According To Cardiologists in Circulation, AHA, European Heart Journal and Medscape Medical News
Posted in Frontiers in Cardiology and Cardiovascular Disorders on January 31, 2021| Leave a Comment »
Most Popular According To Cardiologists in Circulation, AHA, European Heart Journal and Medscape Medical News Reporter: Aviva Lev-Ari, PhD, RN Most Popular According To Cardiologists Saturated Fats and CVD: AHA Convicts, We Say Acquit Independent Nurse Practitioners and Physician Assistants: A Doc’s View from Medscape The Case Against Thrombolytic Therapy in Stroke from theheart.org on Medscape […]
Risks from Dual Antiplatelet Therapy (DAPT) may be reduced by Genotyping Guidance of Cardiac Patients
Posted in CABG, Cardiac and Cardiovascular Surgical Procedures, Frontiers in Cardiology and Cardiovascular Disorders, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology, PCI, Peripheral Arterial Disease & Peripheral Vascular Surgery, Pharmacotherapy of Cardiovascular Disease, Stroke on November 20, 2019| Leave a Comment »
Risks from Dual Antiplatelet Therapy (DAPT) may be reduced by Genotyping Guidance of Cardiac Patients Reporter: Aviva Lev-Ari, PhD, RN Genotyping Cardiac Patients May Reduce Risks From DAPT -STEMI patient study reaches noninferiority mark for adverse cardiac events by Vicki Brower, CME Writer, MedPage Today September 7, 2019 In the investigational arm, all 1,242 patients were tested […]
“Repurposing” Off-patent Drugs offers big hopes of New Treatments
Posted in Drug Delivery Platform Technology, Drug Development Process, tagged Clinical Trials, Drug development, generic drugs, Off-patent drugs, Regulatory on June 29, 2020| Leave a Comment »
“Repurposing” Off-patent Drugs offers big hopes of New Treatments Reporter: Irina Robu, PhD Given the substantial costs and the slow pace of drug discovery and development, repurposing old drugs has become a practice, partly because it involves the use of already developed compounds. Yet, there is lack of clinical interest in repurposing off patent drugs. […]
NEW GENRE Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases – Series A, Volume 5
Posted in on June 7, 2022|
Original Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases NEW GENRE Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-five-pharmacological-agents-in-treatment-of-cardiovascular-diseases-series-a-volume-5/ This volume has the following three parts: PART A: The eTOCs in Spanish in Audio format PART B: The eTOCs in Bi-lingual format: Spanish and English in Text format PART C: The Editorials of the original e-Books in […]
Two Classes of Antithrombotic Drugs: Anticoagulants and Antiplatelet drugs
Posted in Acute coronary syndrome, Acute Myocardial Infarction, Atherogenic Processes & Pathology, Cardiovascular Research, Coagulation Therapy and Internal Bleeding, congestive heart failure, endovascular thrombectomy, Frontiers in Cardiology and Cardiovascular Disorders, Hematology, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease, Stents & Tools, Stroke, Valves & Tools, Vascular Diseases on June 25, 2018| Leave a Comment »
UPDATED on 2/25/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02 25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active ICER announced plans to look at icosapent ethyl (Vascepa) and rivaroxaban (Xarelto) as add-on therapies in cardiovascular disease. Heart attack risk is rising among young women. But NHANES data show women are still ahead of men on control of hypertension, diabetes, and cholesterol. (Circulation) Two Classes of Antithrombotic Drugs: Anticoagulants and Antiplatelet drugs Reporter: […]
Aortic Stenosis (AS): Managed Surgically by Transcatheter Aortic Valve Replacement (TAVR) – Search Results for “TAVR” on NIH.GOV website, Top 16 pages
Posted in Aortic Valve: TAVR, TAVI vs Open Heart Surgery, Atherogenic Processes & Pathology, Cardiac and Cardiovascular Surgical Procedures, Congenital Heart Disease, Frontiers in Cardiology and Cardiovascular Disorders, Medical Devices R&D and Inventions, Origins of Cardiovascular Disease, TAVI vs Open Heart Surgery, Valves & Tools on August 14, 2018| Leave a Comment »
Aortic Stenosis (AS): Managed Surgically by Transcatheter Aortic Valve Replacement (TAVR) – Search Results for “TAVR” on NIH.GOV website, Top 16 pages Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 9/24/2018 Sapien 3, CoreValve Evolut R on Par for Aortic Stenosis Head-to-head trial also shows local, general anesthesia outcomes similar by Ashley Lyles, Staff Writer, MedPage Today September 23, […]
Follow Blog via Email
-
Recent Posts
- Sperm damage and fertility problem due to COVID-19 June 23, 2022
- Genomic data can predict miscarriage and IVF failure June 15, 2022
- The Human Genome Gets Fully Sequenced: A Simplistic Take on Century Long Effort June 14, 2022
- Aortic Valve Transplant Via Carotid Artery at Hadassah – An Israel First May 29, 2022
- Omecamtiv mecarbil – A study examined efficacy and tolerability in Heart Failure patients with SBP ≤100 mmHg enrolled in GALACTIC-HF May 23, 2022
- Sperm epigenetic clock and pregnancy outcomes May 14, 2022
- Lessons on the Frontier of Gene & Cell Therapy – The Disruptive Dozen 12 #GCT Breakthroughs that are revolutionizing Healthcare May 9, 2022
- Relevance of Twitter.com forthcoming Payment System for Scientific Content Promotion and Monetization May 9, 2022
- Tweets at #WMIF2022 by @pharma_BI & @AVIVA1950 and all Retweets of these Tweets – 2022 World Medical Innovation Forum, GENE & CELL THERAPY • MAY 2–4, 2022 • BOSTON May 7, 2022
- Data Science: Step by Step – A Resource for LPBI Group’s One-Year Internship in IT, IS, DS May 7, 2022
Archives
Categories
Meta
-
2012pharmaceutical
-
Amandeep Kaur
-
Aashir Awan, Phd
-
Abhisar Anand
-
Adina Hazan
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
dsmolyar
-
Ethan Coomber
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jayzmit48
-
jdpmd
-
jshertok
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
Madison Davis
-
marzankhan
-
megbaker58
-
ofermar2020
-
Dr. Pati
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
Srinivas Sriram
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
vaishnavee24
-
zraviv06
-
zs22
-
